Literature DB >> 36271342

Thematic analysis of the raters' experiences administering scales to assess depression and suicide in Arab schizophrenia patients.

Iman Amro1, Suhaila Ghuloum2, Samer Hammoudeh1, Yahya Hani2, Arij Yehya1, Hassen Al-Amin3.   

Abstract

BACKGROUND: This study aimed to enhance the cultural adaptation and training on administering the Arabic versions of the Calgary Depression Scale in Schizophrenia (CDSS) and The International Scale for Suicidal Thinking (ISST) to Arab schizophrenia patients in Doha, Qatar.
METHODS: We applied the qualitative thematic analysis of the focus group discussions with clinical research coordinators (CRCs). Five CRCs met with the principal investigator for two sessions; we transcribed the conversations and analyzed the content.
RESULTS: This study revealed one set of themes related to the scales themselves, like the role of the clinician-patient relationship during administration, the semantic variations in Arabic dialects, and the design of scales to assess suicide and differentiate between negative symptoms and depression. The other set of themes is relevant to the sociocultural domains of Muslim Arabs, covering religion, families' roles, and stigma. It also covered the approaches to culturally sensitive issues like suicide, taboos in Islam, and the gender roles in Arab countries and their impact on the patients' reports of their symptoms.
CONCLUSIONS: Our results highlight several cultural and religious aspects to tackle when approaching schizophrenia patients through in-depth discussions and training to improve the validity of the assessment tools and treatment services.
© 2022. The Author(s).

Entities:  

Keywords:  Arabs; Cultural adaptation; Depression; Schizophrenia; Suicide; Thematic analysis

Year:  2022        PMID: 36271342     DOI: 10.1186/s12888-022-04313-3

Source DB:  PubMed          Journal:  BMC Psychiatry        ISSN: 1471-244X            Impact factor:   4.144


  52 in total

Review 1.  Suicide and schizophrenia.

Authors:  S G Siris
Journal:  J Psychopharmacol       Date:  2001-06       Impact factor: 4.153

Review 2.  Occurrence and treatment of depressive comorbidity/cosyndromality in schizophrenic psychoses: conceptual and treatment issues.

Authors:  Hans-Jürgen Möller
Journal:  World J Biol Psychiatry       Date:  2005       Impact factor: 4.132

3.  Depressive and negative symptoms in schizophrenia: different effects on clinical features.

Authors:  Paola Rocca; Silvio Bellino; Paolo Calvarese; Livio Marchiaro; Luca Patria; Roberta Rasetti; Filippo Bogetto
Journal:  Compr Psychiatry       Date:  2005 Jul-Aug       Impact factor: 3.735

4.  Quality of life in schizophrenic patients: association with depressive symptoms.

Authors:  Vibeke Nørholm; Per Bech
Journal:  Nord J Psychiatry       Date:  2006       Impact factor: 2.202

5.  Depressive episodes in stable schizophrenia: critical evaluation of the DSM-IV and ICD-10 diagnostic criteria.

Authors:  Rodrigo A Bressan; Ana C Chaves; Lyn S Pilowsky; Itiro Shirakawa; Jair J Mari
Journal:  Psychiatry Res       Date:  2003-01-25       Impact factor: 3.222

6.  Exploring depression in schizophrenia.

Authors:  Carlo Maggini; Andrea Raballo
Journal:  Eur Psychiatry       Date:  2005-12-13       Impact factor: 5.361

7.  A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders.

Authors:  L L Judd; H S Akiskal; J D Maser; P J Zeller; J Endicott; W Coryell; M P Paulus; J L Kunovac; A C Leon; T I Mueller; J A Rice; M B Keller
Journal:  Arch Gen Psychiatry       Date:  1998-08

8.  Specificity of the Calgary Depression Scale for schizophrenics.

Authors:  D Addington; J Addington; E Maticka-Tyndale
Journal:  Schizophr Res       Date:  1994-02       Impact factor: 4.939

Review 9.  Schizophrenia: a concise overview of incidence, prevalence, and mortality.

Authors:  John McGrath; Sukanta Saha; David Chant; Joy Welham
Journal:  Epidemiol Rev       Date:  2008-05-14       Impact factor: 6.222

10.  Depression and subjective quality of life in chronic phase schizophrenic patients.

Authors:  G Reine; C Lançon; S Di Tucci; C Sapin; P Auquier
Journal:  Acta Psychiatr Scand       Date:  2003-10       Impact factor: 6.392

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.